Table of Contents · Sandra A. Moriarity, Senior Production Editor Sharon L. Quimby, Managing...

7
Table of Contents Neurology.org/nn Online ISSN: 2332-7812 Volume 2, Number 4, August 2015 EDITORS CORNER e137 The rst anniversary issue J. Dalmau EDITORIAL e140 Unique invariant CD8 1 T cell population persists in MS J.J. Sabatino, Jr and S.S. Zamvil Companion article, e107 ARTICLES e107 ab T-cell receptors from multiple sclerosis brain lesions show MAIT cellrelated features K. Held, L. Bhonsle-Deeng, K. Siewert, W. Sato, E. Beltrán, S. Schmidt, G. Rühl, J.K.M. Ng, P. Engerer, M. Moser, W.E.F. Klinkert, H. Babbe, T. Misgeld, H. Wekerle, D.-A. Laplaud, R. Hohlfeld, and K. Dornmair Editorial, e140 e119 Complement activity is associated with disease severity in multifocal motor neuropathy L. Vlam, E.A. Cats, O. Harschnitz, M.D. Jansen, S. Piepers, J.H. Veldink, H. Franssen, A.C.J. Stork, E. Heezius, S.H.M. Rooijakkers, B.L. Herpers, J.A. van Strijp, L.H. van den Berg, and W.L. van der Pol e109 Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations E. Schuh, P. Lohse, B. Ertl-Wagner, M. Witt, M. Krumbholz, M. Frankenberger, L.-A. Gerdes, R. Hohlfeld, and T. Kümpfel e111 Hippocampal volume and depressive symptoms are linked to serum IL-18 in schizophrenia P. Bossù, F. Piras, I. Palladino, M. Iorio, F. Salani, A. Ciaramella, C. Chiapponi, C. Caltagirone, and G. Spalletta e120 Oral contraceptives combined with interferon b in multiple sclerosis C. Pozzilli, L. De Giglio, V.T. Barletta, F. Marinelli, F.D. Angelis, V. Gallo, V.A. Pagano, S. Marini, M.C. Piattella, V. Tomassini, and P. Pantano e123 Hematologic modications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study C. Bridel, Y. Beauverd, K. Samii, and P.H. Lalive e113 Acute lower motor neuron syndrome and spinal cord gray matter hyperintensities in HIV infection I.I. Bogoch, M.R. Wilson, D.A. Chad, and N. Venna e121 Aquaporin-4 antibody isoform binding specicities do not explain clinical variations in NMO J. Kitley, M. Woodhall, M.I. Leite, J. Palace, A. Vincent, and P. Waters e117 Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis C.S. Constantinescu, A. Asher, W. Fryze, W. Kozubski, F. Wagner, J. Aram, R. Tanasescu, R.P. Korolkiewicz, M. Dirnberger-Hertweck, S. Steidl, S.E. Libretto, T. Sprenger, and E.W. Radue e124 Myopathy with anti-HMGCR antibodies: Perimysium and myober pathology A. Alshehri, R. Choksi, R. Bucelli, and A. Pestronk e122 ILAE type 3 hippocampal sclerosis in patients with anti-GADrelated epilepsy R.L. Glover, L.V. DeNiro, P.A. Lasala, K.M. Weidenheim, J.J. Graber, and A. Boro ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

Transcript of Table of Contents · Sandra A. Moriarity, Senior Production Editor Sharon L. Quimby, Managing...

Table of ContentsNeurology.org/nn � Online ISSN: 2332-7812Volume 2, Number 4, August 2015

EDITOR’S CORNER

e137 The first anniversary issueJ. Dalmau

EDITORIAL

e140 Unique invariant CD81 T cell population persistsin MSJ.J. Sabatino, Jr and S.S. Zamvil

Companion article, e107

ARTICLES

e107 ab T-cell receptors frommultiple sclerosis brain lesionsshow MAIT cell–related featuresK. Held, L. Bhonsle-Deeng, K. Siewert, W. Sato,E. Beltrán, S. Schmidt, G. Rühl, J.K.M. Ng, P. Engerer,M. Moser, W.E.F. Klinkert, H. Babbe, T. Misgeld,H. Wekerle, D.-A. Laplaud, R. Hohlfeld, andK. Dornmair

Editorial, e140

e119 Complement activity is associatedwithdisease severityin multifocal motor neuropathyL. Vlam, E.A. Cats, O. Harschnitz, M.D. Jansen,S. Piepers, J.H. Veldink, H. Franssen, A.C.J. Stork,E. Heezius, S.H.M. Rooijakkers, B.L. Herpers,J.A. van Strijp, L.H. van den Berg, andW.L. van der Pol

e109 Expanding spectrum of neurologic manifestationsin patients with NLRP3 low-penetrancemutationsE. Schuh, P. Lohse, B. Ertl-Wagner, M. Witt,M. Krumbholz, M. Frankenberger, L.-A. Gerdes,R. Hohlfeld, and T. Kümpfel

e111 Hippocampal volume and depressive symptoms arelinked to serum IL-18 in schizophreniaP. Bossù, F. Piras, I. Palladino, M. Iorio, F. Salani,A. Ciaramella, C. Chiapponi, C. Caltagirone, andG. Spalletta

e120 Oral contraceptives combined with interferon b inmultiple sclerosisC. Pozzilli, L. De Giglio, V.T. Barletta, F. Marinelli,F.D. Angelis, V. Gallo, V.A. Pagano, S. Marini,M.C. Piattella, V. Tomassini, and P. Pantano

e123 Hematologic modifications in natalizumab-treatedmultiple sclerosis patients: An 18-monthlongitudinal studyC. Bridel, Y. Beauverd, K. Samii, andP.H. Lalive

e113 Acute lower motor neuron syndrome andspinal cord gray matter hyperintensities inHIV infectionI.I. Bogoch, M.R. Wilson, D.A. Chad, and N. Venna

e121 Aquaporin-4 antibody isoform binding specificities donot explain clinical variations in NMOJ. Kitley, M. Woodhall, M.I. Leite, J. Palace,A. Vincent, and P. Waters

e117 Randomized phase 1b trial of MOR103, a humanantibody to GM-CSF, in multiple sclerosisC.S. Constantinescu, A. Asher, W. Fryze,W. Kozubski, F. Wagner, J. Aram, R. Tanasescu,R.P. Korolkiewicz, M. Dirnberger-Hertweck,S. Steidl, S.E. Libretto, T. Sprenger, andE.W. Radue

e124 Myopathy with anti-HMGCR antibodies: Perimysiumand myofiber pathologyA. Alshehri, R. Choksi, R. Bucelli, and A. Pestronk

e122 ILAE type 3 hippocampal sclerosis in patients withanti-GAD–related epilepsyR.L. Glover, L.V. DeNiro, P.A. Lasala,K.M. Weidenheim, J.J. Graber, and A. Boro

ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

e132 Predictive value of early brain atrophy on response inpatients treated with interferon b

F.C. Pérez-Miralles, J. Sastre-Garriga,A. Vidal-Jordana, J. Río, C. Auger, D. Pareto,M. Tintoré, A. Rovira, and X. Montalban

e127 Caspr2 autoantibodies target multiple epitopesA.L. Olsen, Y. Lai, J. Dalmau, S.S. Scherer, andE. Lancaster

e129 Impact of MS genetic loci on familialaggregation, clinical phenotype, and diseasepredictionF. Esposito, C. Guaschino, M. Sorosina, F. Clarelli,L. Ferre’, E. Mascia, S. Santoro, M. Pagnesi,M. Radaelli, B. Colombo, L. Moiola, M. Rodegher,E. Stupka, V. Martinelli, G. Comi, andF.M. Boneschi

VIEWS & REVIEWS

e110 Aquaporin-4 autoimmunityA. Zekeridou and V.A. Lennon

e135 Acute optic neuritis: Unmet clinical needs and modelfor new therapiesS.L. Galetta, P. Villoslada, N. Levin, K. Shindler,H. Ishikawa, E. Parr, D. Cadavid, andL.J. Balcer

e134 Update on biomarkers in neuromyelitisopticaE. Melamed, M. Levy, P.J. Waters, D.K. Sato,J.L. Bennett, G.R. John, D.C. Hooper,A. Saiz, A. Bar-Or, H.J. Kim, L. Pandit,M.I. Leite, N. Asgari, N. Kissani, R. Hintzen,R. Marignier, S. Jarius, J. Marcelletti, T.J. Smith,M.R. Yeaman, and M.H. Han, on behalf of theGJCF-ICC&BR

CLINICAL/SCIENTIFIC NOTES

e108 Varicella-zoster virus encephalitis localized to thebilateral medial temporal lobesR. Yajima, K. Utsumi, T. Ishihara, M. Kanazawa,K. Okamoto, I. Kawachi, and M. Nishizawa

e114 Allergic encephalitis with gelastic status epilepticusinduced by wasp stingR. Jimenez-Sanders, R. Behrouz, andN. Tsakadze

e118 Posterior cortical and white matter changes on MRI inanti-AMPA receptor antibody encephalitisM. Elamin, R. Lonergan, R.P. Killeen, S. O’Riordan,N. Tubridy, and C. McGuigan

e128 Diagnostic value of MRI in inflammatory myositisT.T. Lai and T. Mozaffar

e130 Earlier treatment of NMDAR antibody encephalitis inchildren results in a better outcomeS. Byrne, C.Walsh, Y. Hacohen, E. Muscal, J. Jankovic,A. Stocco, R.C. Dale, A. Vincent, M. Lim, and M. King

e125 Widespread arterial infection by varicella-zoster virusexplains refractory giant cell arteritisD.Gilden, T.White, S.L. Galetta, F. Fogt, andM.A. Nagel

e126 Transient anti-NMDAR encephalitis in a newborn infantdue to transplacental transmissionM. Hilderink, M.J. Titulaer, M.W.J. Schreurs, K. Keizer,and J.E.H. Bunt

e136 Sleep disorder, chorea, and dementia associated withIgLON5 antibodiesM.M. Simabukuro, L. Sabater, T. Adoni, R.G. Cury,M.S. Haddad, C.H. Moreira, L. Oliveira,M. Boaventura, R.C. Alves, L.A. Soster, R. Nitrini,C. Gaig, J. Santamaria, J. Dalmau, and F. Graus

Table of Contentscontinued

ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

e131 Anti-MOG antibodies are frequently associated withsteroid-sensitive recurrent optic neuritisK. Chalmoukou, H. Alexopoulos, S. Akrivou,P. Stathopoulos, M. Reindl, and M.C. Dalakas

CORRECTION

e133 Encephalomyeloneuropathy with CRMP-5antibodies in a patient with a primary mediastinalserinoma

Video LOE classification LOE recommendation Podcast

tinyurl.com/NeurologyNN twitter.com/GreenJournal

Cover image: HMGCR-antibody associated myopathy with involvement of perimysialconnective tissue and muscle fibers demonstrated by abnormal alkaline phosphatase stain.See “Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology.”

Table of Contentscontinued

ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

Neurology.org/nn � Online ISSN: 2332-7812Volume 2, Number 4, August 2015

VISION: Neurology: Neuroimmunology & Neuroinflammation will bethe premier peer-reviewed journal for experts in the fields ofNeuroimmunology and Neuroinflammation.

MISSION: Neurology: Neuroimmunology & Neuroinflammation willprovide neurologists with peer-reviewed articles, editorials, andreviews to enhance patient care, education, and clinical &translational research.

EditorNeurology: Neuroimmunology & NeuroinflammationJosep O. Dalmau, MD, PhDICREA-University of BarcelonaBarcelona, SpainUniversity of PennsylvaniaPhiladelphia, PATel: 612-928-6400Toll-free: 800-957-3182 (US)Fax: [email protected]

Editor-in-ChiefNeurology®Robert A. Gross, MD, PhD, FAANProfessor of Neurology and of Pharmacology and PhysiologyStrong Epilepsy CenterUniversity of Rochester Medical CenterRochester, NYTel: 612-928-6400Toll-free: 800-957-3182 (US)Fax: [email protected]

Editorial InquiriesTel: 612-928-6400Toll-free: 800-957-3182 (US)Fax: [email protected]

Academy OfficersTerrence L. Cascino, MD, FAAN, PresidentRalph L. Sacco, MD, MS, FAAN, President ElectJames C. Stevens, MD, FAAN, Vice PresidentAaron E. Miller, MD, FAAN, SecretaryLisa M. Shulman, MD, FAAN, TreasurerTimothy A. Pedley, MD, FAAN, Past President

Executive Office, American Academy of NeurologyCatherine M. Rydell, CAE, Executive Director/CEO201 Chicago AveMinneapolis, MN 55415Tel: 612-928-6100

Editorial OfficePatricia K. Baskin, MS, Executive EditorKathleen M. Pieper, Managing Editor, NeurologySandra A. Moriarity, Senior Production EditorSharon L. Quimby, Managing Editor, Neurology® Clinical PracticeMorgan S. Sorenson, Managing Editor, Neurology: Neuroimmunology

& NeuroinflammationLee Ann Kleffman, Managing Editor, Neurology® GeneticsCynthia S. Abair, MA, Senior Graphics EditorRobert J. Witherow, Senior Editorial AssociateKaren Skaja, Editorial AssociateAndrea R. Wagner, Editorial AssistantKaitlyn Aman Ramm, Editorial AssistantKristen Swendsrud, Editorial Assistant

PublisherWolters KluwerBaltimore, MD

Publishing StaffKim Jansen, Executive PublisherAlexandra Lazerow, Production Team Leader, AAN JournalsStephanie Abrahams, Senior Production EditorNick Strickland, Production Associate

ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

Neurology.org/nn � Online ISSN: 2332-7812Volume 2, Number 4, August 2015

EDITORNeurology: Neuroimmunology & NeuroinflammationJosep O. Dalmau, MD, PhDICREA-University of BarcelonaBarcelona, SpainUniversity of PennsylvaniaPhiladelphia, PA

EDITOR-IN-CHIEFNeurologyRobert A. Gross, MD, PhD, FAANProfessor of Neurology and of Pharmacology and PhysiologyStrong Epilepsy CenterUniversity of Rochester Medical CenterRochester, NY

DEPUTY EDITORSNeurologyDavid S. Knopman, MD, FAANProfessor of NeurologyDepartment of NeurologyCollege of MedicineMayo ClinicRochester, MN

Neurology: Neuroimmunology & NeuroinflammationScott S. Zamvil, MD, PhD, FAANDepartment of NeurologyUniversity of California, San FranciscoSan Francisco, CA

ASSOCIATE EDITORSNeurology: Neuroimmunology & NeuroinflammationMichael Heneka, MDUniversity of BonnBonn, GermanySpecialties: Neurodegeneration, stroke

Robyn S. Klein, MD, PhDWashington University School of MedicineSt. Louis, MOSpecialty: Infectious disease

Friedmann Paul, MDCharite University HospitalBerlin, GermanySpecialties: Multiple sclerosis, neuromyelitis optica, neuroimaging(magnetic resonance imaging, optical coherence tomography)

Lan Zhou, MD, PhDMount Sinai School of MedicineNew York, NYSpecialty: Neuromuscular

EDITORIAL BOARDRohit Aggarwal, MD, MS, University of Pittsburgh, Pittsburgh, PASergio E. Baranzini, PhD, University of San Francisco, San Francisco, CASusanne Benseler, MD, Calgary, Alberta, CanadaJeffrey L. Bennett, MD, PhD, FAAN, University of Colorado, Aurora, COSéverine Boillée, PhD, Hôpital de la Salpêtriere, Paris, FranceMatthijs C. Brouwer, MD, PhD, Adademic Medical Center, Amsterdam,The Netherlands

David B.Clifford,MD, FAAN,WashingtonUniversity School ofMedicine,St. Louis, MO

Russell C. Dale, MBChB, MRCP, PhD, University of Sydney, Sydney,Australia

Oscar H. Del Brutto, MD, FAAN, Clinica, Kennedy, Guayaquil,Ecuador

Thomas G. Forsthuber, MD, University of Texas, San Antonio, TXJoseph El Khoury, MD, Massachusetts General Hospital, Boston, MAMarkus P. Kummer, PhD, University of Bonn, Bonn, GermanyJun Li, MD, PhD, Vanderbilt University, Nashville, TNLin Mei, MD, PhD, Georgia Regents University, Augusta, GeorgiaChristopher Power, MD, University of Alberta, Alberta, CanadaRichard M. Ransohoff, MD, Biogen Idec, Boston, MAChristine Stadelmann, MD, University of Göttingen, Göttingen,Germany

Israel Steiner, MD, Rabin Medical Center, Petach Tikva, IsraelLawrence Steinman, MD, FAAN, Stanford University, Stanford, CAJesper Tegnér, PhD, MSc, Karolinska University Hospital, Stockholm,Sweden

Maarten J. Titulaer, MD, PhD, Erasmus Medical Center, Rotterdam,The Netherlands

Hugh J. Willison, MBBS, PhD, University of Glasgow, Glasgow, UK

LEVEL OF EVIDENCE REVIEW TEAMMelissa J. Armstrong, MD, Baltimore, MDRichard L. Barbano, MD, PhD, FAAN, Rochester, NYRichard M. Dubinsky, MD, MPH, FAAN, Kansas City, KSJeffrey J. Fletcher, MD, MSc, Ann Arbor, MIGary M. Franklin, MD, MPH, FAAN, Seattle, WADavid S. Gloss II, MD, MPH&TM, Danville, PAJohn J. Halperin, MD, FAAN, Summit, NJJason Lazarou, MSc, MD, Toronto, Ontario, CanadaSteven R. Messé, MD, FAAN, Philadelphia, PAPushpa Narayanaswami, MBBS, DM, FAAN, Boston, MAAlex Rae-Grant, MD, Cleveland, OH

ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

Neurology.org/nn � Online ISSN: 2332-7812Volume 2, Number 4, August 2015

Publication InformationNeurology® is a registered trademark of the American Academy of Neurology (registration valid in the United States).

Neurology® Neuroimmunology & Neuroinflammation (eISSN 2332-7812) is an open access journal published online for the American Academyof Neurology, 201 Chicago Ave, Minneapolis, MN 55415, by Wolters Kluwer, 16522 Hunters Green Parkway, Hagerstown, MD 21740-2116.Business offices are located at TwoCommerce Square, 2001Market St., Philadelphia, PA 19103. Production offices are located at 351West CamdenStreet, Baltimore, MD 21201-2436. © 2015 American Academy of Neurology.

Neurology® Neuroimmunology & Neuroinflammation is an official journal of the American Academy of Neurology.Journal website: Neurology.org/nn, AAN website: AAN.com

Copyright and Permission Information: Please go to the journal website (www.neurology.org/nn) and click the “©Request Permissions” iconfor the relevant article. Alternatively, send an email to [email protected]. General information about permissions can be found here:http://www.lww.com/webapp/wcs/stores/servlet/content_resources_permissions-journals_11851_-1_12551.

Translation Rights & Licensing queries: Silvia Serra, Director of Rights, Licensing& Permissions,Wolters Kluwer Health (Medical Research) Ltd,250 Waterloo Road, London SE1 8RD, UK. tel: 144-207-9810600; [email protected].

Disclaimer:Opinions expressed by the authors and advertisers are not necessarily those of the American Academy of Neurology, its affiliates, orof the Publisher. The American Academy of Neurology, its affiliates, and the Publisher disclaim any liability to any party for the accuracy,completeness, efficacy, or availability of the material contained in this publication (including drug dosages) or for any damages arising out of theuse or non-use of any of the material contained in this publication.

Advertising Sales Representatives: Wolters Kluwer, 333 Seventh Avenue, New York, NY 10001. Contacts: Eileen Henry, tel: 732-778-2261, fax:973-215-2485, [email protected] and Valentin Torres, tel: 646-674-6354, cell: 646-628-4530, fax: 917-677-8420, [email protected]. In Europe: Avia Potashnik, Wolters Kluwer, tel: 144 207 981 0722; 144 7919 397 933 or e-mail: [email protected].

Careers & Events: Ryan Magee, Wolters Kluwer, Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel: 215-521-8804,fax: 215-521-8801; [email protected].

Reprints: Ben Beit-Zuri, Wolters Kluwer, 333 Seventh Avenue, New York, NY 10001, [email protected], [email protected].

Special projects: US & Canada: Alan Moore, Wolters Kluwer, Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel:215-521-8638, [email protected]. International: Silvia Serra, Director of Rights, Licensing & Permissions, Wolters KluwerHealth (Medical Research), Ltd, 250 Waterloo Road, London SE1 8RD, UK. Tel: 144-207-9810600; [email protected].

ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

2015;2; Neurol Neuroimmunol Neuroinflamm 2 (4)

This information is current as of January 1, 2015

ServicesUpdated Information &

http://nn.neurology.org/content/2/4.full.htmlincluding high resolution figures, can be found at:

  Permissions & Licensing

http://nn.neurology.org/misc/about.xhtml#permissionsits entirety can be found online at:Information about reproducing this article in parts (figures,tables) or in

  Reprints

http://nn.neurology.org/misc/addir.xhtml#reprintsusInformation about ordering reprints can be found online:

rights reserved. Online ISSN: 2332-7812.Published since April 2014, it is an open-access, online-only, continuous publication journal. Copyright . All

is an official journal of the American Academy of Neurology.Neurol Neuroimmunol Neuroinflamm